Altering an established Continued Process Verification (CPV) process is difficult because of regulatory challenges. But simply assisting CPV – leaving the regulatory portion untouched – can have significant benefits.

The importance of asset reliability has increased multifold for the pharma industry and hence upgraded methodologies of reliability management like software-defined reliability are required.